Article

Ten tips for the ophthalmologist in ordering neuro-imaging

MRI is in general superior to CT for neuro-ophthalmic indications. A CT study, however, might be useful [under certain circumstances].

The roles of the comprehensive ophthalmologist are 1) localize the neuro-ophthalmic problem; 2) select the most appropriate imaging study; and 3) provide sufficient clinical information to the neuroradiologist to allow the best interpretation of the films. If the ophthalmologist is unable or unwilling to complete these tasks, then referral to a neuro-ophthalmologist is a reasonable alternative.

The neuroradiologist should be called, however, if there is any question on the type of study that would best suit the clinical needs.

Timely and adequate communication between the ordering ophthalmologist and the interpreting neuroradiologist is the most important message of this brief report.

Andrew G. Lee, MD, is professor of ophthalmology, neurology, and neurosurgery, The H. Stanley Thompson Neuro-ophthalmology Clinic, Department of Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City. He can be reach by phone at 319/384-7372, fax at 319/353-7996, or by e-mail: andrew-lee@uiowa.edu
.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
© 2025 MJH Life Sciences

All rights reserved.